Lilly, Novo Nordisk near White House deals on obesity drug prices, Endpoints News reports – Reuters
- Lilly, Novo Nordisk near White House deals on obesity drug prices, Endpoints News reports Reuters
- Lilly and Novo near White House deal on obesity drug prices Endpoints News
- Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried? The Motley Fool
- Lilly and Novo near White House deal on obesity drug prices – Endpoints News StreetInsider
- Novo Nordisk, Lilly nearing deal on obesity drug pricing, says UBS TipRanks